Pulmonx Corporation (LUNG) vs SkinHealth Systems Inc. (SKIN)

A side-by-side comparison of Pulmonx Corporation and SkinHealth Systems Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LUNG vs SKIN

growth of $100 · dividends reinvested · last 6y
LUNG -96.3% (-42.3%/yr)SKIN -94.5% (-38.3%/yr)SKIN compounded faster over this window
0100200Start $100202120222023202420252026$4$6
LUNG SKIN

LUNG vs SKIN: by the numbers

  • •SKIN is the larger company ($76M vs $75M market cap).
  • •Both run net losses; SKIN's is the smaller (-9.79% vs -55.03% net margin).
  • •LUNG grew revenue faster over the past five years (15.86% vs 9.24% CAGR).

Metrics side by side

Valuation

MetricLUNGSKIN
P/S ratio0.860.26
P/B ratio1.911.36
EV / EBITDAN/A10.31
FCF yieldN/A21.95%

Profitability

MetricLUNGSKIN
Gross margin77.06%66.34%
Operating margin-52.96%-1.49%
Net margin-55.03%-9.79%
ROE-122.76%-51.09%
ROIC-48.39%-1.02%

Growth (annualized)

MetricLUNGSKIN
Revenue CAGR (5Y)15.86%9.24%
Total return CAGR (5Y)-45.30%-53.07%

Frequently asked

Which has grown faster, LUNG or SKIN?
Over the past five years, LUNG grew revenue faster — LUNG at a 15.86% CAGR versus SKIN at 9.24%.
How have LUNG and SKIN total returns compared?
Over the past 5 years, LUNG delivered -45.30% and SKIN delivered -53.07% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.